Fragment-Masked Molecular Optimization

• URL: http://arxiv.org/abs/2408.09106v1
• Date: Sat, 17 Aug 2024 06:00:58 GMT
• Title: Fragment-Masked Molecular Optimization
• Authors: Kun Li, Xiantao Cai, Jia Wu, Bo Du, Wenbin Hu,
• Abstract summary: We propose a fragment-masked molecular optimization method based on phenotypic drug discovery (PDD) PDD-based molecular optimization can reduce potential safety risks while optimizing phenotypic activity, thereby increasing the likelihood of clinical success. The overall experiments demonstrate that the in-silico optimization success rate reaches 94.4%, with an average efficacy increase of 5.3%.
• Score: 37.20936761888007
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Molecular optimization is a crucial aspect of drug discovery, aimed at refining molecular structures to enhance drug efficacy and minimize side effects, ultimately accelerating the overall drug development process. Many target-based molecular optimization methods have been proposed, significantly advancing drug discovery. These methods primarily on understanding the specific drug target structures or their hypothesized roles in combating diseases. However, challenges such as a limited number of available targets and a difficulty capturing clear structures hinder innovative drug development. In contrast, phenotypic drug discovery (PDD) does not depend on clear target structures and can identify hits with novel and unbiased polypharmacology signatures. As a result, PDD-based molecular optimization can reduce potential safety risks while optimizing phenotypic activity, thereby increasing the likelihood of clinical success. Therefore, we propose a fragment-masked molecular optimization method based on PDD (FMOP). FMOP employs a regression-free diffusion model to conditionally optimize the molecular masked regions without training, effectively generating new molecules with similar scaffolds. On the large-scale drug response dataset GDSCv2, we optimize the potential molecules across all 945 cell lines. The overall experiments demonstrate that the in-silico optimization success rate reaches 94.4%, with an average efficacy increase of 5.3%. Additionally, we conduct extensive ablation and visualization experiments, confirming that FMOP is an effective and robust molecular optimization method. The code is available at:https://anonymous.4open.science/r/FMOP-98C2.

Related papers

• Diversity-Aware Reinforcement Learning for de novo Drug Design [2.356290293311623]
  Fine-tuning a pre-trained generative model has demonstrated good performance in generating promising drug molecules. No study has examined how different adaptive update mechanisms for the reward function influence the diversity of generated molecules. Our experiments reveal that combining structure- and prediction-based methods generally yields better results in terms of molecular diversity.
  arXiv  Detail & Related papers  (2024-10-14T12:25:23Z)
• Aligning Target-Aware Molecule Diffusion Models with Exact Energy Optimization [147.7899503829411]
  AliDiff is a novel framework to align pretrained target diffusion models with preferred functional properties. It can generate molecules with state-of-the-art binding energies with up to -7.07 Avg. Vina Score.
  arXiv  Detail & Related papers  (2024-07-01T06:10:29Z)
• Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
  Conditional generation based on the target IC50 score can obtain a more effective sampling space. Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
  arXiv  Detail & Related papers  (2024-05-23T13:22:17Z)
• Guided Multi-objective Generative AI to Enhance Structure-based Drug Design [0.0]
  We describe IDOLpro, a generative chemistry AI combining diffusion with multi-objective optimization for structure-based drug design. IDOLpro produces with binding affinities over 10%-20% better than the next best state-of-the-art method on each test set. We show that IDOLpro can generate molecules for a range of important disease-related targets with better binding affinity and synthetic accessibility than any molecule found in the virtual screen.
  arXiv  Detail & Related papers  (2024-05-20T05:08:55Z)
• Improving Targeted Molecule Generation through Language Model Fine-Tuning Via Reinforcement Learning [0.0]
  We introduce an innovative de-novo drug design strategy, which harnesses the capabilities of language models to devise targeted drugs for specific proteins. Our method integrates a composite reward function, combining considerations of drug-target interaction and molecular validity.
  arXiv  Detail & Related papers  (2024-05-10T22:19:12Z)
• Multi-objective Molecular Optimization for Opioid Use Disorder Treatment Using Generative Network Complex [5.33208055504216]
  Opioid Use Disorder (OUD) has emerged as a significant global health issue. In this study, we propose a deep generative model that combines a differential equation (SDE)-based diffusion modeling with the latent space of a pretrained autoencoder model. The molecular generator enables efficient generation of molecules that are effective on multiple targets.
  arXiv  Detail & Related papers  (2023-06-13T01:12:31Z)
• Exploring Chemical Space with Score-based Out-of-distribution Generation [57.15855198512551]
  We propose a score-based diffusion scheme that incorporates out-of-distribution control in the generative differential equation (SDE) Since some novel molecules may not meet the basic requirements of real-world drugs, MOOD performs conditional generation by utilizing the gradients from a property predictor. We experimentally validate that MOOD is able to explore the chemical space beyond the training distribution, generating molecules that outscore ones found with existing methods, and even the top 0.01% of the original training pool.
  arXiv  Detail & Related papers  (2022-06-06T06:17:11Z)
• Optimizing Molecules using Efficient Queries from Property Evaluations [66.66290256377376]
  We propose QMO, a generic query-based molecule optimization framework. QMO improves the desired properties of an input molecule based on efficient queries. We show that QMO outperforms existing methods in the benchmark tasks of optimizing small organic molecules.
  arXiv  Detail & Related papers  (2020-11-03T18:51:18Z)
• MIMOSA: Multi-constraint Molecule Sampling for Molecule Optimization [51.00815310242277]
  generative models and reinforcement learning approaches made initial success, but still face difficulties in simultaneously optimizing multiple drug properties. We propose the MultI-constraint MOlecule SAmpling (MIMOSA) approach, a sampling framework to use input molecule as an initial guess and sample molecules from the target distribution.
  arXiv  Detail & Related papers  (2020-10-05T20:18:42Z)
• Molecular Design in Synthetically Accessible Chemical Space via Deep Reinforcement Learning [0.0]
  We argue that existing generative methods are limited in their ability to favourably shift the distributions of molecular properties during optimization. We propose a novel Reinforcement Learning framework for molecular design in which an agent learns to directly optimize through a space of synthetically-accessible drug-like molecules.
  arXiv  Detail & Related papers  (2020-04-29T16:29:28Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.